Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

SANOFI : Former Sanofi employees convicted of bribery in Germany

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/03/2014 | 07:24pm CET

A German court convicted two former employees of Sanofi-Aventis on bribery charges 10 months ago and imposed a fine on the French drugmaker last year, prosecutors said on Monday following a newspaper report.

News of the 28 million euro ($39 million) fine coincides with heightened scrutiny of Big Pharma's sales practices after a bribery scandal in China hit business there last year.

Further investigations are ongoing, a spokesman for prosecutors in the northern German town of Verden said, confirming a report by German daily newspaper Frankfurter Allgemeine Zeitung, but they declined to say whether these were related to Sanofi or to its employees.

The spokesman said an investigation of the former Sanofi employees found that they had made illicit payments to a consultancy advising one of the drugmaker's clients between 2007 and 2010 to win more orders from the client, a pharmaceuticals dealer.

"Sanofi was unfairly given preference because of this," he said.

He declined to provide details on who the client was or which markets it operated in. He also did not name the former Sanofi employees or the consultant.

A court in the town of Winsen handed the two former employees of Sanofi suspended sentences for bribery in business transactions in May 2013, the spokesman said. They both worked with Sanofi's sales force and were not senior managers.

The Winsen court also ordered that punishment be meted out to the owner of the consultancy, but that judgment was not yet final due to a pending complaint against the ruling.

The bribery investigation has not come to light until now because the suspects were sentenced via a simplified legal process that under German law allows courts to try some crimes without a courtroom trial.

The court's ruling also resulted in a 28 million euro fine for Sanofi. A spokeswoman for Sanofi-Aventis Deutschland GmbH confirmed the company had to pay that sum in connection with the case against the two former employees.

"For Sanofi the matter is closed," the spokeswoman said, referring to the Winsen court's rulings. She added the company had cooperated with authorities during the investigation and had since further tightened its compliance system.

Sanofi acquired Aventis in 2004, creating Sanofi-Aventis. In 2011, the company simplified its name to Sanofi.

(Reporting by Maria Sheahan and Frank Siebelt; Additional reporting by Natalie Huet in Paris; Writing by Marilyn Gerlach; editing by Mike Collett-White)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
04:01p SANOFI : and Regeneron Announce Marketing Authorization Application for Dupixent..
03:17p SANOFI : Dengue vaccine to be introduced in Pakistan in 2017
02:07p EMA REVIEWS REGENERON PHARMACEUTICAL : REGN), Sanofi SA (ADR) (NYSE:SNY) Dupixen..
02:05pDJBayer Teams Up With Versant to Develop Stem-Cell Therapies--Update
12:23p SANOFI : Dengue vaccine to be introduced in Pakistan in 2017
12/08 MYMETICS : Starts Research Project with Sanofi for Influenza Vaccines
12/08 SANOFI : New Findings on Type 1 Diabetes Mellitus Described by Investigators at ..
12/08 Sanofi mulls counterbid for Actelion amid J&J talks
12/08 SANOFI : NJ Community-based Home Care Agency Receives Monetary Donation from the..
12/08 SANOFI : and Regeneron Announce Marketing Authorization Application for Dupixent..
More news
Sector news : Pharmaceuticals - NEC
02:05pDJBayer Teams Up With Versant to Develop Stem-Cell Therapies--Update
12/08 BRISTOL MYERS SQUIBB : Meyers Squibb to pay $19.5 million to settle off-label pr..
12/07 MYLAN : EpiPen maker Mylan to restructure, cut workforce
12/07DJABBOTT LABORATORIES : Seeks to Terminate Alere Deal -- Update
12/07DJPFIZER : Fined $107 Million for Overcharging U.K. for Epilepsy Drug
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
12/08 Dupilumab marketing application under review in Europe
12/07 ET TU, DONALD? DRUGS DIVE : What's Going On, And What's Next
12/07 Bayer buys Boehringer's CYDECTIN vet products in U.S.
12/07 Sanofi buys $10M of insulin from MannKind under settlement agreement
12/06 Microsoft Defeats Salesforce; LinkedIn Deal Set To Close
Advertisement
Financials (€)
Sales 2016 36 745 M
EBIT 2016 9 379 M
Net income 2016 5 255 M
Debt 2016 5 778 M
Yield 2016 4,00%
P/E ratio 2016 16,65
P/E ratio 2017 15,18
EV / Sales 2016 2,79x
EV / Sales 2017 2,81x
Capitalization 96 810 M
More Financials
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 81,3 €
Spread / Average Target 8,3%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jérôme Contamine Chief Financial Officer & EVP-Finance
Elias E. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI-4.45%102 757
JOHNSON & JOHNSON8.05%301 952
ROCHE HOLDING LTD.-19.97%189 184
PFIZER INC.-3.38%187 755
NOVARTIS AG-20.79%178 671
MERCK & CO., INC.13.82%165 759
More Results